Insmed
INSM
INSM
114 hedge funds and large institutions have $970M invested in Insmed in 2017 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 30 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.86% less ownership
Funds ownership: 91.9% → 91.04% (-0.86%)
3% less capital invested
Capital invested by funds: $998M → $970M (-$28.3M)
71% less call options, than puts
Call options by funds: $6.39M | Put options by funds: $21.8M
Holders
114
Holding in Top 10
1
Calls
$6.39M
Puts
$21.8M
Top Buyers
| 1 | +$28.3M | |
| 2 | +$9.24M | |
| 3 | +$8.15M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.62M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$4.12M |
Top Sellers
| 1 | -$8.81M | |
| 2 | -$8.08M | |
| 3 | -$7.93M | |
| 4 |
O
OrbiMed
New York
|
-$7.16M |
| 5 |
Morgan Stanley
New York
|
-$2.33M |